BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8546897)

  • 1. bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas.
    Pollina L; Pacini F; Fontanini G; Vignati S; Bevilacqua G; Basolo F
    Br J Cancer; 1996 Jan; 73(2):139-43. PubMed ID: 8546897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland.
    Pilotti S; Collini P; Rilke F; Cattoretti G; Del Bo R; Pierotti MA
    J Pathol; 1994 Apr; 172(4):337-42. PubMed ID: 8207614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
    Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
    Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
    Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
    Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 and p53 expression in insular and in well-differentiated thyroid carcinomas with an insular pattern.
    Peştereli HE; Oğüş M; Oren N; Karpuzoğlu G; Kerpuzoğlu T
    Endocr Pathol; 2001; 12(3):301-5. PubMed ID: 11740051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 expression in colorectal tumours. Correlation with p53, mdm-2, Rb proteins and proliferation indices.
    Goussia AC; Ioachim E; Agnantis NJ; Mahera M; Tsianos EV
    Histol Histopathol; 2000 Jul; 15(3):667-72. PubMed ID: 10963109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2 and proliferating cell nuclear antigen (PCNA) expression correlates with subsequent local recurrence in nasopharyngeal carcinomas.
    Tsai ST; Jin YT; Leung HW; Wang ST; Tsao CJ; Su IJ
    Anticancer Res; 1998; 18(4B):2849-54. PubMed ID: 9713473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactivity of p53, Ki-67, and Bcl-2 in oncocytic adenomas and carcinomas of the thyroid gland.
    Müller-Höcker J
    Hum Pathol; 1999 Aug; 30(8):926-33. PubMed ID: 10452505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
    Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U
    Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression.
    Saltman B; Singh B; Hedvat CV; Wreesmann VB; Ghossein R
    Surgery; 2006 Dec; 140(6):899-905; discussion 905-6. PubMed ID: 17188136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Malamou-Mitsi V; Kamina SA; Goussia AC; Agnantis NJ
    Anticancer Res; 2000; 20(6B):4221-5. PubMed ID: 11205251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of bcl-2 and p53 oncoproteins: correlation with Ki67 proliferation index and prognostic histopathologic parameters in colorectal neoplasia.
    Saleh HA; Jackson H; Banerjee M
    Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):175-82. PubMed ID: 10981868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the antiapoptotic protein bcl-2 is not dependent on the tumor suppressor p53 protein in Indian breast carcinoma.
    Kesari AL; Chellam VG; Madhavan J; Nair PP; Nair MK; Pillai MR
    Pathobiology; 1997; 65(2):108-12. PubMed ID: 9253035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of bcl-2, p53 oncoprotein, and proliferating cell nuclear antigen in renal cell carcinoma.
    Sejima T; Miyagawa I
    Eur Urol; 1999; 35(3):242-8. PubMed ID: 10072628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas.
    Diebold J; Baretton G; Felchner M; Meier W; Dopfer K; Schmidt M; Löhrs U
    Am J Clin Pathol; 1996 Mar; 105(3):341-9. PubMed ID: 8602616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis and proliferation related molecules (Bcl-2, Bax, p53, PCNA) in papillary microcarcinoma versus papillary carcinoma of the thyroid.
    Cvejic D; Selemetjev S; Savin S; Paunovic I; Petrovic I; Tatic S
    Pathology; 2008 Aug; 40(5):475-80. PubMed ID: 18604733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid.
    Soares P; Cameselle-Teijeiro J; Sobrinho-Simões M
    Histopathology; 1994 Mar; 24(3):205-10. PubMed ID: 8200621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of retinoblastoma gene product (Rb), p53 protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder carcinoma.
    Ioachim E; Charchanti A; Stavropoulos NE; Skopelitou A; Athanassiou ED; Agnantis NJ
    Histol Histopathol; 2000 Jul; 15(3):721-7. PubMed ID: 10963116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.